194 related articles for article (PubMed ID: 16699034)
1. A herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors.
Menotti L; Cerretani A; Campadelli-Fiume G
J Virol; 2006 Jun; 80(11):5531-9. PubMed ID: 16699034
[TBL] [Abstract][Full Text] [Related]
2. Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2.
Menotti L; Cerretani A; Hengel H; Campadelli-Fiume G
J Virol; 2008 Oct; 82(20):10153-61. PubMed ID: 18684832
[TBL] [Abstract][Full Text] [Related]
3. The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors.
Gatta V; Petrovic B; Campadelli-Fiume G
PLoS Pathog; 2015 May; 11(5):e1004907. PubMed ID: 25996983
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors.
Leoni V; Petrovic B; Gianni T; Gatta V; Campadelli-Fiume G
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263255
[TBL] [Abstract][Full Text] [Related]
5. Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
Ikeda H; Uchida H; Okubo Y; Shibata T; Sasaki Y; Suzuki T; Hamada-Uematsu M; Hamasaki R; Okuda K; Yamaguchi M; Kojima M; Tanaka M; Hamada H; Tahara H
J Virol; 2021 Apr; 95(9):. PubMed ID: 33627393
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
7. A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein.
Conner J; Braidwood L; Brown SM
Gene Ther; 2008 Dec; 15(24):1579-92. PubMed ID: 18701918
[TBL] [Abstract][Full Text] [Related]
8. Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.
Petrovic B; Gianni T; Gatta V; Campadelli-Fiume G
PLoS Pathog; 2017 Apr; 13(4):e1006352. PubMed ID: 28423057
[TBL] [Abstract][Full Text] [Related]
9. The herpes simplex virus JMP mutant enters receptor-negative J cells through a novel pathway independent of the known receptors nectin1, HveA, and nectin2.
Cocchi F; Menotti L; Di Ninni V; Lopez M; Campadelli-Fiume G
J Virol; 2004 May; 78(9):4720-9. PubMed ID: 15078954
[TBL] [Abstract][Full Text] [Related]
10. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
Leoni V; Gatta V; Casiraghi C; Nicosia A; Petrovic B; Campadelli-Fiume G
J Virol; 2017 May; 91(10):. PubMed ID: 28250120
[TBL] [Abstract][Full Text] [Related]
11. Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.
Fan Q; Kopp S; Connolly SA; Muller WJ; Longnecker R
Sci Rep; 2017 Mar; 7():43712. PubMed ID: 28255168
[TBL] [Abstract][Full Text] [Related]
12. Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D.
Sciortino MT; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè-Cuculletto M; Venuti A; Grelli S; Mastino A
Cell Microbiol; 2008 Nov; 10(11):2297-311. PubMed ID: 18671825
[TBL] [Abstract][Full Text] [Related]
13. Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.
Connolly SA; Landsburg DJ; Carfi A; Wiley DC; Cohen GH; Eisenberg RJ
J Virol; 2003 Jul; 77(14):8127-40. PubMed ID: 12829851
[TBL] [Abstract][Full Text] [Related]
14. Contributions of gD receptors and glycosaminoglycan sulfation to cell fusion mediated by herpes simplex virus 1.
Terry-Allison T; Montgomery RI; Warner MS; Geraghty RJ; Spear PG
Virus Res; 2001 Apr; 74(1-2):39-45. PubMed ID: 11226572
[TBL] [Abstract][Full Text] [Related]
15. A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia.
Huang TH; Morrison SL
J Pharmacol Exp Ther; 2006 Mar; 316(3):983-91. PubMed ID: 16291729
[TBL] [Abstract][Full Text] [Related]
16. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H
J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
18. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
Chan SD; Antoniucci DM; Fok KS; Alajoki ML; Harkins RN; Thompson SA; Wada HG
J Biol Chem; 1995 Sep; 270(38):22608-13. PubMed ID: 7673253
[TBL] [Abstract][Full Text] [Related]
19. Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells.
Daniels TR; Leuchter RK; Quintero R; Helguera G; Rodríguez JA; Martínez-Maza O; Schultes BC; Nicodemus CF; Penichet ML
Cancer Immunol Immunother; 2012 Jul; 61(7):991-1003. PubMed ID: 22127364
[TBL] [Abstract][Full Text] [Related]
20. The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1.
Zhou G; Avitabile E; Campadelli-Fiume G; Roizman B
J Virol; 2003 Mar; 77(6):3759-67. PubMed ID: 12610150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
